Biobanking in India: Road to Translation Research and Precision Medicine Initiative

Suchi Vaidya, Khushbu Shah, Pooja Utekar, Simran Keshwani, Abhishek Prajapati, Prashant Khadke

Abstract: Non-Communicable diseases are on a rise and India reports one of the highest number of cases for diabetes, cardiovascular diseases, chronic kidney diseases, mental health disorders and cancer. These cases have increased and made the people even more vulnerable after the SARS COV - 19 pandemic. In the age of Precision Medicine, it is time to tap the diversity in the country in terms of culture, ethnicity and genetic variability. Tapping the diversity will not only help in the drug discoveries but also to help make the treatment regimens more streamlined and with lesser side effects. This can be achieved with the help of biobanking which is in its infancy stage as of now in India. There are multiple small biobanks in the country however, forming a consortium of these biobanks is the need of the hour.

Keywords: Biobanks, Data, Electronic Health Records (EHR), Regulatory Guidelines

How to Cite?: Suchi Vaidya, Khushbu Shah, Pooja Utekar, Simran Keshwani, Abhishek Prajapati, Prashant Khadke, "Biobanking in India: Road to Translation Research and Precision Medicine Initiative", Volume 13 Issue 2, February 2024, International Journal of Science and Research (IJSR), Pages: 1811-1815, https://www.ijsr.net/getabstract.php?paperid=SR24226162101, DOI: https://dx.doi.org/10.21275/SR24226162101